QT
ARCT icon

Quantbot Technologies’s Arcturus Therapeutics ARCT Stock Holding History

Quantbot Technologies’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,100
Closed -$118K – 1522
2023
Q2 		$118K Sell
4,100
-3,200
-44% -$87.1K 0.01% 1134
2023
Q1 		$175K Buy
7,300
+5,004
+218% +$89.8K 0.01% 940
2022
Q4 		$38.9K Buy
+2,296
New +$40K ﹤0.01% 1347
2022
Q1 		– Sell
-900
Closed -$33K – 1619
2021
Q4 		$33K Buy
900
+500
+125% +$20.4K ﹤0.01% 1132
2021
Q3 		$19K Buy
+400
New +$17.9K ﹤0.01% 1276
2021
Q2 		– Sell
-1,286
Closed -$53K – 1436
2021
Q1 		$53K Buy
+1,286
New +$76.7K 0.01% 997

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Quantbot Technologies's ARCT Position: Q3 2023 in Review

Quantbot Technologies sold out of Arcturus Therapeutics (ARCT) in Q3 2023, closing a stake of 4,100 shares — an estimated $118K sold.

Quantbot Technologies first reported a position in ARCT in Q1 2021 and held it in 6 quarters. The position peaked at $175K in Q1 2023. 145 funds tracked by Wall St. Rank hold ARCT as of Q3 2023.

  • Quantbot Technologies reported no remaining Arcturus Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Quantbot Technologies sold 4,100 Arcturus Therapeutics shares in Q3 2023, an estimated $118K.
  • Quantbot Technologies first reported a position in Arcturus Therapeutics in Q1 2021 and held it in 6 quarters.
  • Quantbot Technologies's Arcturus Therapeutics position peaked at $175K in Q1 2023.
  • 145 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.